About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Massachusetts | 1,146 Studies

Clinical Trials Breast CancerMassachusetts

Breast Cancer Clinical Trials in Massachusetts

Find 1,146 clinical trials for breast cancer near Massachusetts. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 521-540 of 1,146 trials

RecruitingPhase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsThis is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects…NCT05232916·Mobile, Alabama and 178 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast CancerThis is a Phase 1/2 dose escalation and cohort expansion study and will assess the safety, tolerability and anti-tumor activity of ARV-471 alone and in combination with…NCT04072952·Palo Alto, California and 15 others

CompletedBone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3RATIONALE: Learning about the effect of exemestane on bone mineral density in postmenopausal women at increased risk of breast cancer may help plan treatment, decrease the risk of…NCT00688246·Torrance, California and 17 others

RecruitingInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerThis research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or has been diagnosed…NCT05463796·Boston, Massachusetts

TerminatedCelecoxib in Treating Women With Metastatic or Recurrent Breast CancerRATIONALE: Celecoxib may stop the growth of tumor cells by blocking the enzymes necessary for their growth and by stopping blood flow to the tumor.NCT00045591·Anniston, Alabama and 73 others

RecruitingSHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsThe clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on metastatic pancreatic cancer and metastatic breast cancer.NCT04150042·Boston, Massachusetts and 1 other

CompletedStudy To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast CancerThis is a Phase III, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of bevacizumab administered in combination with paclitaxel…NCT01663727·Birmingham, Alabama and 177 others

Active not recruitingA Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid TumorsThis will be a Phase 1, multicenter, open-label trial to evaluate the safety, tolerability, PK and efficacy of ZN-A-1041 as a monotherapy or in combination in participants with…NCT05593094·Tucson, Arizona and 35 others

CompletedA Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast CancerTo compare treatment with SU011248 plus paclitaxel versus bevacizumab plus paclitaxel to determine which treatment works better against breast cancerNCT00373256·Bessemer, Alabama and 249 others

CompletedA Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast CancerThis is a randomized, Phase III, open-label, multicenter study.NCT00789581·Anniston, Alabama and 69 others

CompletedOral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast CancerThe objective of this study is to evaluate the efficacy, safety and pharmacokinetics of DHP107 (Oral Paclitaxel, Korea brand name: Liporaxel®) compared to IV Paclitaxel in…NCT03326102·Los Angeles, California and 14 others

RecruitingTrastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast CancerThis study will evaluate the safety and efficacy of trastuzumab deruxtecan (T-DXd) in participants with human epidermal growth factor receptor 2 (HER2)-low or HER2…NCT05950945·Miami Beach, Florida and 87 others

CompletedER Reactivation Therapy for Breast CancerBefore anti-estrogens such as tamoxifen were developed to treat estrogen receptor (ER)-positive breast cancer, high-dose estrogen therapies were used.NCT02188745·Springfield, Massachusetts and 2 others

CompletedS9832: Effectiveness of Telephone Counseling By Breast Cancer Survivors on the Well-Being of Women With Recurrent Breast CancerRATIONALE: Telephone counseling by breast cancer survivors may enhance the well-being and quality of life of women who have recurrent breast cancer.NCT00031772·Birmingham, Alabama and 108 others

RecruitingRemote Monitoring and Symptom Management Digital ApplicationThe goal of this clinical trial is to learn if an artificial intelligence phone application called ASSIST can help patients receiving cancer treatment.NCT07553572·Boston, Massachusetts

CompletedPatient Perception of Mammogram GuidelinesThe purpose of this study was to determine attitudes regarding the 2009 USPSTF Guidelines for breast cancer screening for women in their 40's and assess the effect of one of two…NCT01267877·Auburn, Massachusetts and 3 others

TerminatedVaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12The purpose of this study is to test the safety of an investigational Dendritic Cell/Tumor Fusion vaccine given with IL-12 for patients with breast cancer.NCT00622401·Boston, Massachusetts

Active not recruitingWeb-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer SurvivorsThis clinical trial compares a web-based patient-reported symptom monitoring and self management portal, the Young, Empowered \& Strong (YES), to standard therapy in managing…NCT04906200·Boston, Massachusetts and 2 others

TerminatedA Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.This was a clinical study with an orally administered drug, BDTX-189 in participants with advanced solid tumors that had select mutations or alterations in human epidermal growth…NCT04209465·Scottsdale, Arizona and 37 others

Active not recruitingStudy of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic DiseaseThe purpose of this study is to determine the safety and efficacy of PF-07220060 with letrozole compared to approved treatments (ie, palbociclib, ribociclib or abemaciclib with…NCT06760637·Birmingham, Alabama and 462 others

PreviousPage 27 of 58Next

Other Conditions in Massachusetts

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma